- Report
- July 2023
- 107 Pages
From €3098EUR$3,450USD£2,638GBP
- Report
- July 2023
- 124 Pages
North America
From €3098EUR$3,450USD£2,638GBP
- Report
- July 2023
- 108 Pages
Africa, Middle East
From €3098EUR$3,450USD£2,638GBP
- Report
- July 2023
- 130 Pages
Europe
From €3098EUR$3,450USD£2,638GBP
- Report
- June 2023
- 134 Pages
Asia Pacific
From €3098EUR$3,450USD£2,638GBP
- Report
- May 2023
- 186 Pages
Global
From €3995EUR$4,450USD£3,402GBP
- Report
- February 2024
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- December 2024
- 85 Pages
Spain
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- May 2023
- 146 Pages
Global
From €3995EUR$4,450USD£3,402GBP
- Report
- September 2023
- 60 Pages
Global
From €444EUR$495USD£378GBP
- Report
- January 2025
- 132 Pages
Global
From €853EUR$950USD£726GBP
- Book
- December 2024
- 400 Pages
AI Based Clinical Trials are a type of clinical trial that uses artificial intelligence (AI) to improve the efficiency and accuracy of the trial process. AI-based clinical trials use machine learning algorithms to automate and streamline the data collection process, allowing for faster and more accurate data analysis. AI-based clinical trials also use natural language processing to automate the process of extracting data from medical records and other sources. This technology can help reduce the time and cost associated with clinical trials, while also improving the accuracy of the data collected. AI-based clinical trials can also help to reduce the risk of bias in the data collected, as the algorithms used are designed to be unbiased.
Some companies in the AI Based Clinical Trials market include IBM Watson Health, Medidata Solutions, and Clinerion. Show Less Read more
